Literature DB >> 28510496

Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review.

Patrick Fleming1, Stephanie Zhou2, Robert Bobotsis3, Charles Lynde1,4.   

Abstract

There are currently several reputable guidelines on the treatment of actinic keratosis (AK) from groups in Canada, the United Kingdom, and Europe. These recommendations, based on evidence or expert consensus, offer clinicians a variety of treatment options for the different clinical presentations of AKs. Although the guidelines are similar in some regards, variations exist in treatment options, duration, and strength of recommendation. Some guidelines also lack input on specific therapies and certain types of AK, such as hypertrophic or thin presentations. The purpose of this article is to review and compare guidelines published by Canadian, UK, and European groups for the management of AKs in patients.

Entities:  

Keywords:  actinic keratoses; actinic keratosis; comparison; guidelines; solar keratosis; treatment

Mesh:

Substances:

Year:  2017        PMID: 28510496     DOI: 10.1177/1203475417708166

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  7 in total

1.  Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015.

Authors:  Howa Yeung; Marissa L Baranowski; Robert A Swerlick; Suephy C Chen; Jennifer Hemingway; Danny R Hughes; Richard Duszak
Journal:  JAMA Dermatol       Date:  2018-11-01       Impact factor: 10.282

2.  Pulsed Dye Laser-mediated Photodynamic Therapy is Less Effective than Conventional Photodynamic Therapy for Actinic Field Cancerization: A Randomized Half-side Comparative Study.

Authors:  Vivian Lindholm; Sari Pitkänen; Marika Schröder; Sonja Hahtola; Helka Sahi; Heini Halme; Kirsi Isoherranen
Journal:  Acta Derm Venereol       Date:  2021-02-19       Impact factor: 3.875

Review 3.  A Review of Existing Therapies for Actinic Keratosis: Current Status and Future Directions.

Authors:  Laura Del Regno; Silvia Catapano; Alessandro Di Stefani; Simone Cappilli; Ketty Peris
Journal:  Am J Clin Dermatol       Date:  2022-02-19       Impact factor: 6.233

4.  Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.

Authors:  E C Noels; L M Hollestein; S van Egmond; M Lugtenberg; L P J van Nistelrooij; P J E Bindels; J van der Lei; R S Stern; T Nijsten; M Wakkee
Journal:  Br J Dermatol       Date:  2019-04-19       Impact factor: 9.302

5.  [Decision criteria and patient characteristics for patient-oriented treatment of field cancerization : Standardized algorithm for personalized treatment concepts].

Authors:  W G Philipp-Dormston; R Aschoff; T von Braunmühl; T Eigentler; T Haalck; K-M Thoms
Journal:  Hautarzt       Date:  2021-04       Impact factor: 0.751

6.  The Overall Number of Actinic Keratosis Lesions Is Not Predictable by the Number of Visible Lesions: Consequences for Field-Directed Therapies.

Authors:  Eggert Stockfleth; Nathalie Bégeault; Alain Delarue
Journal:  Curr Ther Res Clin Exp       Date:  2021-12-22

Review 7.  1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses.

Authors:  Diem-Phuong D Dao; Vikram Nath Sahni; Dev Ram Sahni; Esther A Balogh; Ayman Grada; Steven R Feldman
Journal:  Ann Pharmacother       Date:  2021-07-23       Impact factor: 3.154

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.